{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:57:04Z","timestamp":1792198624218,"version":"4.4.0"},"reference-count":231,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T00:00:00Z","timestamp":1512950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T00:00:00Z","timestamp":1512950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1038\/nrneph.2017.165","type":"journal-article","created":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T00:47:20Z","timestamp":1512953240000},"page":"121-137","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":888,"title":["Advances in the understanding and treatment of sepsis-induced immunosuppression"],"prefix":"10.1038","volume":"14","author":[{"given":"Fabienne","family":"Venet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Monneret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,11]]},"reference":[{"key":"BFnrneph2017165_CR1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer, M.  et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315, 801\u2013810 (2016).","journal-title":"JAMA"},{"key":"BFnrneph2017165_CR2","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.immuni.2014.04.001","volume":"40","author":"CS Deutschman","year":"2014","unstructured":"Deutschman, C. S. & Tracey, K. J. Sepsis: current dogma and new perspectives. Immunity 40, 463\u2013475 (2014).","journal-title":"Immunity"},{"key":"BFnrneph2017165_CR3","doi-asserted-by":"publisher","first-page":"16045","DOI":"10.1038\/nrdp.2016.45","volume":"2","author":"RS Hotchkiss","year":"2016","unstructured":"Hotchkiss, R. S.  et al. Sepsis and septic shock. Nat. Rev. Dis. Primers 2, 16045 (2016).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"BFnrneph2017165_CR4","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1056\/NEJMp1707170","volume":"377","author":"K Reinhart","year":"2017","unstructured":"Reinhart, K.  et al. Recognizing sepsis as a global health priority \u2014 a WHO resolution. N. Engl. J. Med. 377, 414\u2013417 (2017).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2017165_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2017.36","volume":"17","author":"T van der Poll","year":"2017","unstructured":"van der Poll, T., van de Veerdonk, F. L., Scicluna, B. P. & Netea, M. G. The immunopathology of sepsis and potential therapeutic targets. Nat. Rev. Immunol. 17, 407\u2013420 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrneph2017165_CR6","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1097\/00003246-199707000-00001","volume":"25","author":"F Zeni","year":"1997","unstructured":"Zeni, F., Freeman, B. & Natanson, C. Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit. Care Med. 25, 1095\u20131100 (1997).","journal-title":"Crit. Care Med."},{"key":"BFnrneph2017165_CR7","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S1473-3099(13)70001-X","volume":"13","author":"RS Hotchkiss","year":"2013","unstructured":"Hotchkiss, R. S., Monneret, G. & Payen, D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect. Dis. 13, 260\u2013268 (2013).","journal-title":"Lancet Infect. Dis."},{"key":"BFnrneph2017165_CR8","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nri3552","volume":"13","author":"RS Hotchkiss","year":"2013","unstructured":"Hotchkiss, R. S., Monneret, G. & Payen, D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat. Rev. Immunol. 13, 862\u2013874 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrneph2017165_CR9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/00000658-197709000-00002","volume":"186","author":"JL Meakins","year":"1977","unstructured":"Meakins, J. L.  et al. Delayed hypersensitivity: indicator of acquired failure of host defenses in sepsis and trauma. Ann. Surg. 186, 241\u2013250 (1977).","journal-title":"Ann. Surg."},{"key":"BFnrneph2017165_CR10","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1097\/00000658-199522240-00011","volume":"222","author":"NV Christou","year":"1995","unstructured":"Christou, N. V.  et al. The delayed hypersensitivity response and host resistance in surgical patients. 20 years later. Ann. Surg. 222, 534\u2013548 (1995).","journal-title":"Ann. Surg."},{"key":"BFnrneph2017165_CR11","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1172\/JCI115493","volume":"88","author":"C Munoz","year":"1991","unstructured":"Munoz, C.  et al. Dysregulation of in vitro cytokine production by monocytes during sepsis. J. Clin. Invest. 88, 1747\u20131754 (1991).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2017165_CR12","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1097\/00003246-199907000-00002","volume":"27","author":"RS Hotchkiss","year":"1999","unstructured":"Hotchkiss, R. S.  et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit. Care Med. 27, 1230\u20131251 (1999).","journal-title":"Crit. Care Med."},{"key":"BFnrneph2017165_CR13","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1097\/00003246-200009000-00016","volume":"28","author":"RS Hotchkiss","year":"2000","unstructured":"Hotchkiss, R. S.  et al. Rapid onset of intestinal epithelial and lymphocyte apoptotic cell death in patients with trauma and shock. Crit. Care Med. 28, 3207\u20133217 (2000).","journal-title":"Crit. Care Med."},{"key":"BFnrneph2017165_CR14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1378\/chest.112.1.235","volume":"112","author":"RC Bone","year":"1997","unstructured":"Bone, R. C., Grodzin, C. J. & Balk, R. A. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 112, 235\u2013243 (1997).","journal-title":"Chest"},{"key":"BFnrneph2017165_CR15","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nm0697-678","volume":"3","author":"WD Docke","year":"1997","unstructured":"Docke, W. D.  et al. Monocyte deactivation in septic patients: restoration by IFN-\u03b3 treatment. Nat. Med. 3, 678\u2013681 (1997).","journal-title":"Nat. Med."},{"key":"BFnrneph2017165_CR16","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1164\/ajrccm.163.2.2007102","volume":"163","author":"RS Munford","year":"2001","unstructured":"Munford, R. S. & Pugin, J. Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am. J. Respir. Crit. Care Med. 163, 316\u2013321 (2001).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnrneph2017165_CR17","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/nri1943","volume":"6","author":"RS Hotchkiss","year":"2006","unstructured":"Hotchkiss, R. S. & Nicholson, D. W. Apoptosis and caspases regulate death and inflammation in sepsis. Nat. Rev. Immunol. 6, 813\u2013822 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrneph2017165_CR18","doi-asserted-by":"publisher","first-page":"6724","DOI":"10.1073\/pnas.1031788100","volume":"100","author":"RS Hotchkiss","year":"2003","unstructured":"Hotchkiss, R. S.  et al. Adoptive transfer of apoptotic splenocytes worsens survival, whereas adoptive transfer of necrotic splenocytes improves survival in sepsis. Proc. Natl Acad. Sci. USA 100, 6724\u20136729 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph2017165_CR19","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.2174\/138161208784980617","volume":"14","author":"A Ayala","year":"2008","unstructured":"Ayala, A.  et al. Apoptosis in sepsis: mechanisms, clinical impact and potential therapeutic targets. Curr. Pharm. Des. 14, 1853\u20131859 (2008).","journal-title":"Curr. Pharm. Des."},{"issue":"Suppl. 7","key":"BFnrneph2017165_CR20","doi-asserted-by":"publisher","first-page":"S465","DOI":"10.1086\/431998","volume":"41","author":"RS Hotchkiss","year":"2005","unstructured":"Hotchkiss, R. S., Coopersmith, C. M. & Karl, I. E. Prevention of lymphocyte apoptosis \u2014 a potential treatment of sepsis? Clin. Infect. Dis. 41 (Suppl. 7), S465\u2013S469 (2005).","journal-title":"Clin. Infect. Dis."},{"key":"BFnrneph2017165_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/nri.2016.147","volume":"17","author":"I Jorgensen","year":"2017","unstructured":"Jorgensen, I., Rayamajhi, M. & Miao, E. A. Programmed cell death as a defence against infection. Nat. Rev. Immunol. 17, 151\u2013164 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrneph2017165_CR22","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nri.2016.100","volume":"16","author":"K Cadwell","year":"2016","unstructured":"Cadwell, K. Crosstalk between autophagy and inflammatory signalling pathways: balancing defence and homeostasis. Nat. Rev. Immunol. 16, 661\u2013675 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrneph2017165_CR23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.molmed.2009.01.002","volume":"15","author":"YC Hsieh","year":"2009","unstructured":"Hsieh, Y. C., Athar, M. & Chaudry, I. H. When apoptosis meets autophagy: deciding cell fate after trauma and sepsis. Trends Mol. Med. 15, 129\u2013138 (2009).","journal-title":"Trends Mol. Med."},{"key":"BFnrneph2017165_CR24","doi-asserted-by":"publisher","first-page":"e102066","DOI":"10.1371\/journal.pone.0102066","volume":"9","author":"CW Lin","year":"2014","unstructured":"Lin, C. W.  et al. T-Cell autophagy deficiency increases mortality and suppresses immune responses after sepsis. PLoS ONE 9, e102066 (2014).","journal-title":"PLoS ONE"},{"key":"BFnrneph2017165_CR25","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1097\/CCM.0000000000002016","volume":"45","author":"T Oami","year":"2017","unstructured":"Oami, T.  et al. Suppression of T cell autophagy results in decreased viability and function of T cells through accelerated apoptosis in a murine sepsis model. Crit. Care Med. 45, e77\u2013e85 (2017).","journal-title":"Crit. Care Med."},{"key":"BFnrneph2017165_CR26","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1189\/jlb.3MR0316-118RR","volume":"101","author":"JJ Seeley","year":"2017","unstructured":"Seeley, J. J. & Ghosh, S. Molecular mechanisms of innate memory and tolerance to LPS. J. Leukoc. Biol. 101, 107\u2013119 (2017).","journal-title":"J. Leukoc. Biol."},{"key":"BFnrneph2017165_CR27","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.it.2009.07.009","volume":"30","author":"SK Biswas","year":"2009","unstructured":"Biswas, S. K. & Lopez-Collazo, E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol. 30, 475\u2013487 (2009).","journal-title":"Trends Immunol."},{"key":"BFnrneph2017165_CR28","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1182\/blood.V96.1.218","volume":"96","author":"K Wolk","year":"2000","unstructured":"Wolk, K., Docke, W. D., von Baehr, V., Volk, H. D. & Sabat, R. Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood 96, 218\u2013223 (2000).","journal-title":"Blood"},{"key":"BFnrneph2017165_CR29","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.immuni.2015.02.001","volume":"42","author":"IN Shalova","year":"2015","unstructured":"Shalova, I. N.  et al. Human monocytes undergo functional re-programming during sepsis mediated by hypoxia-inducible factor-1\u03b1. Immunity 42, 484\u2013498 (2015).","journal-title":"Immunity"},{"key":"BFnrneph2017165_CR30","doi-asserted-by":"publisher","first-page":"e68218","DOI":"10.1371\/journal.pone.0068218","volume":"8","author":"F Allantaz-Frager","year":"2013","unstructured":"Allantaz-Frager, F.  et al. Identification of biomarkers of response to IFNg during endotoxin tolerance: application to septic shock. PLoS ONE 8, e68218 (2013).","journal-title":"PLoS ONE"},{"key":"BFnrneph2017165_CR31","doi-asserted-by":"publisher","first-page":"680","DOI":"10.3389\/fimmu.2014.00680","volume":"5","author":"MC Morris","year":"2015","unstructured":"Morris, M. C., Gilliam, E. A. & Li, L. Innate immune programing by endotoxin and its pathological consequences. Front. Immunol. 5, 680 (2015).","journal-title":"Front. Immunol."},{"key":"BFnrneph2017165_CR32","doi-asserted-by":"publisher","first-page":"7110","DOI":"10.4049\/jimmunol.179.10.7110","volume":"179","author":"C van't Veer","year":"2007","unstructured":"van't Veer, C.  et al. Induction of IRAK-M is associated with lipopolysaccharide tolerance in a human endotoxemia model. J. Immunol. 179, 7110\u20137120 (2007).","journal-title":"J. Immunol."},{"key":"BFnrneph2017165_CR33","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/00003246-200101000-00026","volume":"29","author":"T Sfeir","year":"2001","unstructured":"Sfeir, T., Saha, D. C., Astiz, M. & Rackow, E. C. Role of interleukin-10 in monocyte hyporesponsiveness associated with septic shock. Crit. Care Med. 29, 129\u2013133 (2001).","journal-title":"Crit. Care Med."},{"key":"BFnrneph2017165_CR34","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.cell.2016.09.034","volume":"167","author":"B Novakovic","year":"2016","unstructured":"Novakovic, B.  et al. \u03b2-Glucan reverses the epigenetic state of LPS-induced immunological tolerance. Cell 167, 1354\u20131368.e14 (2016).","journal-title":"Cell"},{"key":"BFnrneph2017165_CR35","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/s41598-017-00828-y","volume":"7","author":"MM Muller","year":"2017","unstructured":"Muller, M. M.  et al. Global analysis of glycoproteins identifies markers of endotoxin tolerant monocytes and GPR84 as a modulator of TNF\u03b1 expression. Sci. Rep. 7, 838 (2017).","journal-title":"Sci. Rep."},{"key":"BFnrneph2017165_CR36","doi-asserted-by":"publisher","first-page":"e524","DOI":"10.1097\/CCM.0000000000002294","volume":"45","author":"AJ Hoogendijk","year":"2017","unstructured":"Hoogendijk, A. J.  et al. Sepsis patients display a reduced capacity to activate nuclear factor-\u03baB in multiple cell types. Crit. Care Med. 45, e524\u2013e531 (2017).","journal-title":"Crit. Care Med."},{"key":"BFnrneph2017165_CR37","doi-asserted-by":"publisher","first-page":"aaf1098","DOI":"10.1126\/science.aaf1098","volume":"352","author":"MG Netea","year":"2016","unstructured":"Netea, M. G.  et al. Trained immunity: a program of innate immune memory in health and disease. Science 352, aaf1098 (2016).","journal-title":"Science"},{"key":"BFnrneph2017165_CR38","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.4049\/jimmunol.1601613","volume":"198","author":"SS Chavan","year":"2017","unstructured":"Chavan, S. S. & Tracey, K. J. Essential neuroscience in immunology. J. Immunol. 198, 3389\u20133397 (2017).","journal-title":"J. Immunol."},{"key":"BFnrneph2017165_CR39","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nri1810","volume":"6","author":"EM Sternberg","year":"2006","unstructured":"Sternberg, E. M. Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat. Rev. Immunol. 6, 318\u2013328 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrneph2017165_CR40","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.immuni.2016.12.009","volume":"46","author":"J Dalli","year":"2017","unstructured":"Dalli, J., Colas, R. A., Arnardottir, H. & Serhan, C. N. Vagal regulation of group 3 innate lymphoid cells and the immunoresolvent PCTR1 controls infection resolution. Immunity 46, 92\u2013105 (2017).","journal-title":"Immunity"},{"key":"BFnrneph2017165_CR41","doi-asserted-by":"publisher","first-page":"e0149136","DOI":"10.1371\/journal.pone.0149136","volume":"11","author":"BH Singer","year":"2016","unstructured":"Singer, B. H.  et al. Cecal ligation and puncture results in long-term central nervous system myeloid inflammation. PLoS ONE 11, e0149136 (2016).","journal-title":"PLoS ONE"},{"key":"BFnrneph2017165_CR42","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1113\/jphysiol.2013.268573","volume":"592","author":"D Martelli","year":"2014","unstructured":"Martelli, D., Yao, S. T., McKinley, M. J. & McAllen, R. M. Reflex control of inflammation by sympathetic nerves, not the vagus. J. Physiol. 592, 1677\u20131686 (2014).","journal-title":"J. Physiol."},{"key":"BFnrneph2017165_CR43","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1164\/rccm.201604-0862CP","volume":"194","author":"RF Stolk","year":"2016","unstructured":"Stolk, R. F.  et al. Potentially inadvertent immunomodulation: norepinephrine use in sepsis. Am. J. Respir. Crit. Care Med. 194, 550\u2013558 (2016).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnrneph2017165_CR44","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1146\/annurev-immunol-032712-095956","volume":"31","author":"NJ MacIver","year":"2013","unstructured":"MacIver, N. J., Michalek, R. D. & Rathmell, J. C. Metabolic regulation of T lymphocytes. Annu. Rev. Immunol. 31, 259\u2013283 (2013).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnrneph2017165_CR45","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.cmet.2017.06.001","volume":"26","author":"R Stienstra","year":"2017","unstructured":"Stienstra, R., Netea-Maier, R. T., Riksen, N. P., Joosten, L. A. B. & Netea, M. G. Specific and complex reprogramming of cellular metabolism in myeloid cells during innate immune responses. Cell Metab. 26, 142\u2013156 (2017).","journal-title":"Cell Metab."},{"key":"BFnrneph2017165_CR46","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1189\/jlb.4MR0216-066R","volume":"101","author":"RJ Arts","year":"2017","unstructured":"Arts, R. J., Gresnigt, M. S., Joosten, L. A. & Netea, M. G. Cellular metabolism of myeloid cells in sepsis. J. Leukoc. Biol. 101, 151\u2013164 (2017).","journal-title":"J. Leukoc. Biol."},{"key":"BFnrneph2017165_CR47","doi-asserted-by":"publisher","first-page":"1250684","DOI":"10.1126\/science.1250684","volume":"345","author":"SC Cheng","year":"2014","unstructured":"Cheng, S. C.  et al. mTOR- and HIF-1\u03b1-mediated aerobic glycolysis as metabolic basis for trained immunity. Science 345, 1250684 (2014).","journal-title":"Science"},{"key":"BFnrneph2017165_CR48","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/ni.3398","volume":"17","author":"SC Cheng","year":"2016","unstructured":"Cheng, S. C.  et al. Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis. Nat. Immunol. 17, 406\u2013413 (2016).","journal-title":"Nat. Immunol."},{"key":"BFnrneph2017165_CR49","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.4049\/jimmunol.1700127","volume":"199","author":"F Venet","year":"2017","unstructured":"Venet, F.  et al. IL-7 restores T lymphocyte immunometabolic failure in septic shock patients through mTOR activation. J. Immunol. 199, 1606\u20131615 (2017).","journal-title":"J. Immunol."},{"key":"BFnrneph2017165_CR50","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1042\/CS20150024","volume":"129","author":"MR Edwards","year":"2015","unstructured":"Edwards, M. R.  et al. Metabolic dysfunction in lymphocytes promotes postoperative morbidity. Clin. Sci. 129, 423\u2013437 (2015).","journal-title":"Clin. Sci."},{"key":"BFnrneph2017165_CR51","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0140-6736(04)16815-3","volume":"364","author":"M Singer","year":"2004","unstructured":"Singer, M., De Santis, V., Vitale, D. & Jeffcoate, W. Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet 364, 545\u2013548 (2004).","journal-title":"Lancet"},{"key":"BFnrneph2017165_CR52","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40635-014-0020-3","volume":"2","author":"MA Cazalis","year":"2014","unstructured":"Cazalis, M. A.  et al. Early and dynamic changes in gene expression in septic shock patients: a genome-wide approach. Intensive Care Med. Exp. 2, 20 (2014).","journal-title":"Intensive Care Med. Exp."},{"key":"BFnrneph2017165_CR53","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1084\/jem.20111354","volume":"208","author":"W Xiao","year":"2011","unstructured":"Xiao, W.  et al. A genomic storm in critically injured humans. J. Exp. Med. 208, 2581\u20132590 (2011).","journal-title":"J. Exp. Med."},{"key":"BFnrneph2017165_CR54","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S2213-2600(16)00046-1","volume":"4","author":"EE Davenport","year":"2016","unstructured":"Davenport, E. E.  et al. Genomic landscape of the individual host response and outcomes in sepsis: aprospective cohort study. Lancet Respir. Med. 4, 259\u2013271 (2016).","journal-title":"Lancet Respir. Med."},{"key":"BFnrneph2017165_CR55","doi-asserted-by":"publisher","first-page":"273","DOI":"10.4161\/epi.6.3.14017","volume":"6","author":"WF Carson","year":"2011","unstructured":"Carson, W. F., Cavassani, K. A., Dou, Y. & Kunkel, S. L. Epigenetic regulation of immune cell functions during post-septic immunosuppression. Epigenetics 6, 273\u2013283 (2011).","journal-title":"Epigenetics"},{"key":"BFnrneph2017165_CR56","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1164\/rccm.201301-0036CP","volume":"187","author":"J Leentjens","year":"2013","unstructured":"Leentjens, J., Kox, M., van der Hoeven, J. G., Netea, M. G. & Pickkers, P. Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation. Time for a paradigm change? Am. J. Respir. Crit. Care Med. 187, 1287\u20131293 (2013).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnrneph2017165_CR57","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1128\/MCB.01862-08","volume":"29","author":"M El Gazzar","year":"2009","unstructured":"El Gazzar, M.  et al. Chromatin-specific remodeling by HMGB1 and linker histone H1 silences proinflammatory genes during endotoxin tolerance. Mol. Cell. Biol. 29, 1959\u20131971 (2009).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrneph2017165_CR58","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1074\/jbc.M109.067330","volume":"285","author":"M El Gazzar","year":"2010","unstructured":"El Gazzar, M., Liu, T., Yoza, B. K. & McCall, C. E. Dynamic and selective nucleosome repositioning during endotoxin tolerance. J. Biol. Chem. 285, 1259\u20131271 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph2017165_CR59","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1182\/blood-2007-08-106443","volume":"111","author":"H Wen","year":"2008","unstructured":"Wen, H., Dou, Y., Hogaboam, C. M. & Kunkel, S. L. Epigenetic regulation of dendritic cell-derived interleukin-12 facilitates immunosuppression after a severe innate immune response. Blood 111, 1797\u20131804 (2008).","journal-title":"Blood"},{"key":"BFnrneph2017165_CR60","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/eji.200939739","volume":"40","author":"WFt Carson","year":"2010","unstructured":"Carson, W. F.t.  et al. Impaired CD4+ T-cell proliferation and effector function correlates with repressive histone methylation events in a mouse model of severe sepsis. Eur. J. Immunol. 40, 998\u20131010 (2010).","journal-title":"Eur. J. Immunol."},{"key":"BFnrneph2017165_CR61","doi-asserted-by":"publisher","first-page":"4403","DOI":"10.1182\/blood-2009-09-241083","volume":"115","author":"KA Cavassani","year":"2010","unstructured":"Cavassani, K. A.  et al. The post sepsis-induced expansion and enhanced function of regulatory T cells create an environment to potentiate tumor growth. Blood 115, 4403\u20134411 (2010).","journal-title":"Blood"},{"key":"BFnrneph2017165_CR62","doi-asserted-by":"publisher","first-page":"20940","DOI":"10.1074\/jbc.M110.115063","volume":"285","author":"M El Gazzar","year":"2010","unstructured":"El Gazzar, M. & McCall, C. E. MicroRNAs distinguish translational from transcriptional silencing during endotoxin tolerance. J. Biol. Chem. 285, 20940\u201320951 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph2017165_CR63","doi-asserted-by":"publisher","first-page":"8167273","DOI":"10.1155\/2016\/8167273","volume":"2016","author":"VT Vachharajani","year":"2016","unstructured":"Vachharajani, V. T.  et al. Sirtuins link inflammation and metabolism. J. Immunol. Res. 2016, 8167273 (2016).","journal-title":"J. Immunol. Res."},{"key":"BFnrneph2017165_CR64","doi-asserted-by":"publisher","first-page":"9856","DOI":"10.1074\/jbc.M110.196790","volume":"286","author":"TF Liu","year":"2011","unstructured":"Liu, T. F., Yoza, B. K., El Gazzar, M., Vachharajani, V. T. & McCall, C. E. NAD+-dependent SIRT1 deacetylase participates in epigenetic reprogramming during endotoxin tolerance. J. Biol. Chem. 286, 9856\u20139864 (2011).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph2017165_CR65","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/SHK.0000000000000528","volume":"45","author":"SM Opal","year":"2016","unstructured":"Opal, S. M.  et al. Pharmacological Sirt1 activation improves mortality and markedly alters transcriptional profiles that accompany experimental sepsis. Shock 45, 411\u2013418 (2016).","journal-title":"Shock"},{"key":"BFnrneph2017165_CR66","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1097\/CCM.0000000000000344","volume":"42","author":"E Guerin","year":"2014","unstructured":"Guerin, E.  et al. Circulating immature granulocytes with T-cell killing functions predict sepsis deterioration*. Crit. Care Med. 42, 2007\u20132018 (2014).","journal-title":"Crit. Care Med."},{"key":"BFnrneph2017165_CR67","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1172\/JCI57990","volume":"122","author":"J Pillay","year":"2012","unstructured":"Pillay, J.  et al. A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J. Clin. Invest. 122, 327\u2013336 (2012).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2017165_CR68","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1189\/jlb.4A0415-168RR","volume":"98","author":"J Demaret","year":"2015","unstructured":"Demaret, J.  et al. Marked alterations of neutrophil functions during sepsis-induced immunosuppression. J. Leukoc. Biol. 98, 1081\u20131090 (2015).","journal-title":"J. Leukoc. Biol."},{"key":"BFnrneph2017165_CR69","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1097\/SLA.0000000000001807","volume":"265","author":"P Hampson","year":"2016","unstructured":"Hampson, P.  et al. Neutrophil dysfunction, immature granulocytes, and cell-free DNA are early biomarkers of sepsis in burn-injured patients: a prospective observational cohort study. Ann. Surg. 265, 1241\u20131249 (2016).","journal-title":"Ann. Surg."},{"key":"BFnrneph2017165_CR70","doi-asserted-by":"publisher","first-page":"e0180145","DOI":"10.1371\/journal.pone.0180145","volume":"12","author":"KM Groeneveld","year":"2017","unstructured":"Groeneveld, K. M.  et al. Early decreased neutrophil responsiveness is related to late onset sepsis in multitrauma patients: an international cohort study. PLoS ONE 12, e0180145 (2017).","journal-title":"PLoS ONE"},{"key":"BFnrneph2017165_CR71","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1189\/jlb.5HI0316-128RR","volume":"101","author":"M Gregoire","year":"2017","unstructured":"Gregoire, M.  et al. Frontline Science: HMGB1 induces neutrophil dysfunction in experimental sepsis and in patients who survive septic shock. J. Leukoc. Biol. 101, 1281\u20131287 (2017).","journal-title":"J. Leukoc. Biol."},{"key":"BFnrneph2017165_CR72","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.4049\/jimmunol.1302252","volume":"192","author":"X Huang","year":"2014","unstructured":"Huang, X.  et al. Identification of B7-H1 as a novel mediator of the innate immune\/proinflammatory response as well as a possible myeloid cell prognostic biomarker in sepsis. J. Immunol. 192, 1091\u20131099 (2014).","journal-title":"J. Immunol."},{"key":"BFnrneph2017165_CR73","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1158\/2326-6066.CIR-16-0297","volume":"5","author":"DI Gabrilovich","year":"2017","unstructured":"Gabrilovich, D. I. Myeloid-derived suppressor cells. Cancer Immunol. Res. 5, 3\u20138 (2017).","journal-title":"Cancer Immunol. Res."},{"key":"BFnrneph2017165_CR74","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fcimb.2016.00037","volume":"6","author":"M Ost","year":"2016","unstructured":"Ost, M.  et al. Myeloid-derived suppressor cells in bacterial infections. Front. Cell. Infect. Microbiol. 6, 37 (2016).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"BFnrneph2017165_CR75","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1084\/jem.20062602","volume":"204","author":"MJ Delano","year":"2007","unstructured":"Delano, M. J.  et al. MyD88-dependent expansion of an immature GR-1+CD11b+ population induces T cell suppression and Th2 polarization in sepsis. J. Exp. Med. 204, 1463\u20131474 (2007).","journal-title":"J. Exp. Med."},{"key":"BFnrneph2017165_CR76","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1128\/IAI.00239-12","volume":"80","author":"L Brudecki","year":"2012","unstructured":"Brudecki, L., Ferguson, D. A., McCall, C. E. & El Gazzar, M. Myeloid-derived suppressor cells evolve during sepsis and can enhance or attenuate the systemic inflammatory response. Infect. Immun. 80, 2026\u20132034 (2012).","journal-title":"Infect. Immun."},{"key":"BFnrneph2017165_CR77","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1097\/SHK.0000000000000924","volume":"48","author":"M Albertsmeier","year":"2017","unstructured":"Albertsmeier, M.  et al. Monocyte-dependent suppression of T-cell function in postoperative patients and abdominal sepsis. Shock 48, 651\u2013656 (2017).","journal-title":"Shock"},{"key":"BFnrneph2017165_CR78","doi-asserted-by":"publisher","first-page":"e00066-17","DOI":"10.1128\/IAI.00066-17","volume":"85","author":"MB McPeak","year":"2017","unstructured":"McPeak, M. B.  et al. Myeloid cell-specific knockout of NFI-A improves sepsis survival. Infect. Immun. 85, e00066-17 (2017).","journal-title":"Infect. Immun."},{"key":"BFnrneph2017165_CR79","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1189\/jlb.4HI1216-537R","volume":"102","author":"MB McPeak","year":"2017","unstructured":"McPeak, M. B.  et al. Frontline Science: Myeloid cell-specific deletion of Cebpb decreases sepsis-induced immunosuppression in mice. J. Leukoc. Biol. 102, 191\u2013200 (2017).","journal-title":"J. Leukoc. Biol."},{"key":"BFnrneph2017165_CR80","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1042\/CS20150653","volume":"130","author":"VI Landoni","year":"2016","unstructured":"Landoni, V. I.  et al. Immature myeloid Gr-1+ CD11b+ cells from lipopolysaccharide-immunosuppressed mice acquire inhibitory activity in the bone marrow and migrate to lymph nodes to exert their suppressive function. Clin. Sci. 130, 259\u2013271 (2016).","journal-title":"Clin. Sci."},{"key":"BFnrneph2017165_CR81","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/path.4744","volume":"239","author":"JF Llitjos","year":"2016","unstructured":"Llitjos, J. F.  et al. Sepsis-induced expansion of granulocytic myeloid-derived suppressor cells promotes tumour growth through Toll-like receptor 4. J. Pathol. 239, 473\u2013483 (2016).","journal-title":"J. Pathol."},{"key":"BFnrneph2017165_CR82","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1097\/SLA.0000000000001783","volume":"265","author":"B Mathias","year":"2016","unstructured":"Mathias, B.  et al. Human myeloid-derived suppressor cells are associated with chronic immune suppression after severe sepsis\/septic shock. Ann. Surg. 265, 827\u2013834 (2016).","journal-title":"Ann. Surg."},{"key":"BFnrneph2017165_CR83","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1189\/jlb.5HI0214-074R","volume":"96","author":"H Janols","year":"2014","unstructured":"Janols, H.  et al. A high frequency of MDSCs in sepsis patients, with the granulocytic subtype dominating in gram-positive cases. J. Leukoc. Biol. 96, 685\u2013693 (2014).","journal-title":"J. Leukoc. Biol."},{"key":"BFnrneph2017165_CR84","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1164\/rccm.201606-1143OC","volume":"196","author":"F Uhel","year":"2017","unstructured":"Uhel, F.  et al. Early expansion of circulating granulocytic myeloid-derived suppressor cells predicts development of nosocomial infections in septic patients. Am. J. Respir. Crit. Care Med. 196, 315\u2013327 (2017).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnrneph2017165_CR85","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s00262-012-1294-5","volume":"61","author":"CA Dumitru","year":"2012","unstructured":"Dumitru, C. A., Moses, K., Trellakis, S., Lang, S. & Brandau, S. Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology. Cancer Immunol. Immunother. 61, 1155\u20131167 (2012).","journal-title":"Cancer Immunol. Immunother."},{"key":"BFnrneph2017165_CR86","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/cyto.b.21270","volume":"90","author":"G Monneret","year":"2015","unstructured":"Monneret, G. & Venet, F. Sepsis-induced immune alterations monitoring by flow cytometry as a promising tool for individualized therapy. Cytom. B Clin. Cytom 90, 376\u2013386 (2015).","journal-title":"Cytom. B Clin. Cytom"},{"key":"BFnrneph2017165_CR87","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.coi.2013.05.006","volume":"25","author":"F Venet","year":"2013","unstructured":"Venet, F., Lukaszewicz, A. C., Payen, D., Hotchkiss, R. & Monneret, G. Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies. Curr. Opin. Immunol. 25, 477\u2013483 (2013).","journal-title":"Curr. Opin. Immunol."},{"key":"BFnrneph2017165_CR88","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1089\/sur.2016.014","volume":"17","author":"N Galbraith","year":"2016","unstructured":"Galbraith, N., Walker, S., Carter, J. & Polk, H. C. Jr. Past, present, and future of augmentation of monocyte function in the surgical patient. Surg. Infect. 17, 563\u2013569 (2016).","journal-title":"Surg. Infect."},{"key":"BFnrneph2017165_CR89","doi-asserted-by":"publisher","first-page":"R99","DOI":"10.1186\/cc10112","volume":"15","author":"C Guignant","year":"2011","unstructured":"Guignant, C.  et al. Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients. Crit. Care 15, R99 (2011).","journal-title":"Crit. Care"},{"key":"BFnrneph2017165_CR90","doi-asserted-by":"publisher","first-page":"R70","DOI":"10.1186\/cc10059","volume":"15","author":"Y Zhang","year":"2011","unstructured":"Zhang, Y.  et al. Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients. Crit. Care 15, R70 (2011).","journal-title":"Crit. Care"},{"key":"BFnrneph2017165_CR91","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13054-016-1301-x","volume":"20","author":"R Shao","year":"2016","unstructured":"Shao, R.  et al. Monocyte programmed death ligand-1 expression after 3\u20134 days of sepsis is associated with risk stratification and mortality in septic patients: a prospective cohort study. Crit. Care 20, 124 (2016).","journal-title":"Crit. Care"},{"key":"BFnrneph2017165_CR92","doi-asserted-by":"publisher","unstructured":"Bernsmeier, C.  et al. CD14+CD15\u2212HLA-DR\u2212 myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure. Gut http:\/\/dx.doi.org\/10.1136\/gutjnl-2017-314184 (2017).","DOI":"10.1136\/gutjnl-2017-314184"},{"key":"BFnrneph2017165_CR93","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.molimm.2015.06.030","volume":"68","author":"A Roquilly","year":"2015","unstructured":"Roquilly, A. & Villadangos, J. A. The role of dendritic cell alterations in susceptibility to hospital-acquired infections during critical-illness related immunosuppression. Mol. Immunol. 68, 120\u2013123 (2015).","journal-title":"Mol. Immunol."},{"key":"BFnrneph2017165_CR94","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s00134-006-0436-7","volume":"33","author":"O Guisset","year":"2007","unstructured":"Guisset, O.  et al. Decrease in circulating dendritic cells predicts fatal outcome in septic shock. Intensive Care Med. 33, 148\u2013152 (2007).","journal-title":"Intensive Care Med."},{"key":"BFnrneph2017165_CR95","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1007\/s00134-011-2306-1","volume":"37","author":"D Grimaldi","year":"2011","unstructured":"Grimaldi, D.  et al. Profound and persistent decrease of circulating dendritic cells is associated with ICU-acquired infection in patients with septic shock. Intensive Care Med. 37, 1438\u20131446 (2011).","journal-title":"Intensive Care Med."},{"key":"BFnrneph2017165_CR96","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1189\/jlb.0607357","volume":"83","author":"H Wen","year":"2008","unstructured":"Wen, H., Schaller, M. A., Dou, Y., Hogaboam, C. M. & Kunkel, S. L. Dendritic cells at the interface of innate and acquired immunity: the role for epigenetic changes. J. Leukoc. Biol. 83, 439\u2013446 (2008).","journal-title":"J. Leukoc. Biol."},{"key":"BFnrneph2017165_CR97","doi-asserted-by":"publisher","first-page":"4301","DOI":"10.4049\/jimmunol.1601463","volume":"197","author":"RK Strother","year":"2016","unstructured":"Strother, R. K.  et al. Polymicrobial sepsis diminishes dendritic cell numbers and function directly contributing to impaired primary CD8 T cell responses In Vivo. J. Immunol. 197, 4301\u20134311 (2016).","journal-title":"J. Immunol."},{"key":"BFnrneph2017165_CR98","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.bbrc.2017.06.037","volume":"490","author":"Y Meng","year":"2017","unstructured":"Meng, Y.  et al. CD155 blockade improves survival in experimental sepsis by reversing dendritic cell dysfunction. Biochem. Biophys. Res. Commun. 490, 283\u2013289 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrneph2017165_CR99","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1517\/14712598.7.7.929","volume":"7","author":"X Huang","year":"2007","unstructured":"Huang, X., Venet, F., Chung, C. S., Lomas-Neira, J. & Ayala, A. Changes in dendritic cell function in the immune response to sepsis. Cell- and tissue-based therapy. Expert Opin. Biol. Ther. 7, 929\u2013938 (2007).","journal-title":"Expert Opin. Biol. Ther."},{"key":"BFnrneph2017165_CR100","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.immuni.2017.06.021","volume":"47","author":"A Roquilly","year":"2017","unstructured":"Roquilly, A.  et al. Local modulation of antigen-presenting cell development after resolution of pneumonia induces long-term susceptibility to secondary infections. Immunity 47, 135\u2013147.e5 (2017).","journal-title":"Immunity"},{"key":"BFnrneph2017165_CR101","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/SHK.0b013e3181dc0977","volume":"34","author":"F Venet","year":"2010","unstructured":"Venet, F.  et al. Early assessment of leukocyte alterations at diagnosis of septic shock. Shock 34, 358\u2013363 (2010).","journal-title":"Shock"},{"key":"BFnrneph2017165_CR102","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/00024382-200212000-00001","volume":"18","author":"Y Le Tulzo","year":"2002","unstructured":"Le Tulzo, Y.  et al. Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome. Shock 18, 487\u2013494 (2002).","journal-title":"Shock"},{"key":"BFnrneph2017165_CR103","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/SHK.0000000000000234","volume":"42","author":"AM Drewry","year":"2014","unstructured":"Drewry, A. M.  et al. Persistent lymphopenia after diagnosis of sepsis predicts mortality. Shock 42, 383\u2013391 (2014).","journal-title":"Shock"},{"key":"BFnrneph2017165_CR104","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/SHK.0000000000000347","volume":"43","author":"KP Chung","year":"2015","unstructured":"Chung, K. P.  et al. Severe lymphopenia is associated with elevated plasma interleukin-15 levels and increased mortality during severe sepsis. Shock 43, 569\u2013575 (2015).","journal-title":"Shock"},{"key":"BFnrneph2017165_CR105","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13613-017-0242-0","volume":"7","author":"C Adrie","year":"2017","unstructured":"Adrie, C.  et al. Persistent lymphopenia is a risk factor for ICU-acquired infections and for death in ICU patients with sustained hypotension at admission. Ann. Intensive Care 7, 30 (2017).","journal-title":"Ann. Intensive Care"},{"key":"BFnrneph2017165_CR106","doi-asserted-by":"publisher","first-page":"5850","DOI":"10.4049\/jimmunol.1103616","volume":"188","author":"F Souza-Fonseca-Guimaraes","year":"2012","unstructured":"Souza-Fonseca-Guimaraes, F., Parlato, M., Fitting, C., Cavaillon, J. M. & Adib-Conquy, M. NK cell tolerance to TLR agonists mediated by regulatory T cells after polymicrobial sepsis. J. Immunol. 188, 5850\u20135858 (2012).","journal-title":"J. Immunol."},{"key":"BFnrneph2017165_CR107","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/CCM.0b013e3182676052","volume":"41","author":"F Deknuydt","year":"2013","unstructured":"Deknuydt, F., Roquilly, A., Cinotti, R., Altare, F. & Asehnoune, K. An in vitro model of mycobacterial granuloma to investigate the immune response in brain-injured patients. Crit. Care Med. 41, 245\u2013254 (2013).","journal-title":"Crit. Care Med."},{"key":"BFnrneph2017165_CR108","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1189\/jlb.4HI0616-255R","volume":"100","author":"AC Patera","year":"2016","unstructured":"Patera, A. C.  et al. Frontline Science: Defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1. J. Leukoc. Biol. 100, 1239\u20131254 (2016).","journal-title":"J. Leukoc. Biol."},{"key":"BFnrneph2017165_CR109","doi-asserted-by":"publisher","first-page":"e110585","DOI":"10.1371\/journal.pone.0110585","volume":"9","author":"H Hou","year":"2014","unstructured":"Hou, H.  et al. Tim-3 negatively mediates natural killer cell function in LPS-induced endotoxic shock. PLoS ONE 9, e110585 (2014).","journal-title":"PLoS ONE"},{"key":"BFnrneph2017165_CR110","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jss.2016.08.099","volume":"208","author":"Y Shindo","year":"2017","unstructured":"Shindo, Y.  et al. Anti-PD-L1 peptide improves survival in sepsis. J. Surg. Res. 208, 33\u201339 (2017).","journal-title":"J. Surg. Res."},{"key":"BFnrneph2017165_CR111","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1097\/CCM.0b013e318260c90e","volume":"40","author":"L Chiche","year":"2012","unstructured":"Chiche, L.  et al. Interferon-gamma production by natural killer cells and cytomegalovirus in critically ill patients. Crit. Care Med. 40, 3162\u20133169 (2012).","journal-title":"Crit. Care Med."},{"key":"BFnrneph2017165_CR112","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1126\/science.1210301","volume":"334","author":"CH Wong","year":"2011","unstructured":"Wong, C. H., Jenne, C. N., Lee, W. Y., Leger, C. & Kubes, P. Functional innervation of hepatic iNKT cells is immunosuppressive following stroke. Science 334, 101\u2013105 (2011).","journal-title":"Science"},{"key":"BFnrneph2017165_CR113","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1189\/jlb.4A1215-581R","volume":"101","author":"Y Shindo","year":"2017","unstructured":"Shindo, Y.  et al. Interleukin 7 immunotherapy improves host immunity and survival in a two-hit model of Pseudomonas aeruginosa pneumonia. J. Leukoc. Biol. 101, 543\u2013554 (2017).","journal-title":"J. Leukoc. Biol."},{"key":"BFnrneph2017165_CR114","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s00134-013-3163-x","volume":"40","author":"D Grimaldi","year":"2014","unstructured":"Grimaldi, D.  et al. Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections. Intensive Care Med. 40, 192\u2013201 (2014).","journal-title":"Intensive Care Med."},{"key":"BFnrneph2017165_CR115","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/eji.201141692","volume":"42","author":"A Mohr","year":"2012","unstructured":"Mohr, A.  et al. Sepsis leads to a reduced antigen-specific primary antibody response. Eur. J. Immunol. 42, 341\u2013352 (2012).","journal-title":"Eur. J. Immunol."},{"key":"BFnrneph2017165_CR116","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1084\/jem.20101715","volume":"208","author":"KM Kelly-Scumpia","year":"2011","unstructured":"Kelly-Scumpia, K. M.  et al. B cells enhance early innate immune responses during bacterial sepsis. J. Exp. Med. 208, 1673\u20131682 (2011).","journal-title":"J. Exp. Med."},{"key":"BFnrneph2017165_CR117","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1126\/science.1215173","volume":"335","author":"PJ Rauch","year":"2012","unstructured":"Rauch, P. J.  et al. Innate response activator B cells protect against microbial sepsis. Science 335, 597\u2013601 (2012).","journal-title":"Science"},{"key":"BFnrneph2017165_CR118","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.aaa4268","volume":"347","author":"GF Weber","year":"2015","unstructured":"Weber, G. F.  et al. Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis. Science 347, 1260\u20131265 (2015).","journal-title":"Science"},{"key":"BFnrneph2017165_CR119","doi-asserted-by":"publisher","first-page":"750","DOI":"10.4049\/jimmunol.1602056","volume":"199","author":"M Aziz","year":"2017","unstructured":"Aziz, M., Holodick, N. E., Rothstein, T. L. & Wang, P. B-1a cells protect mice from sepsis: critical role of CREB. J. Immunol. 199, 750\u2013760 (2017).","journal-title":"J. Immunol."},{"key":"BFnrneph2017165_CR120","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1172\/JCI85113","volume":"127","author":"C Mauri","year":"2017","unstructured":"Mauri, C. & Menon, M. Human regulatory B cells in health and disease: therapeutic potential. J. Clin. Invest. 127, 772\u2013779 (2017).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2017165_CR121","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1097\/CCM.0000000000002380","volume":"45","author":"M Shankar-Hari","year":"2017","unstructured":"Shankar-Hari, M.  et al. Activation-associated accelerated apoptosis of memory B cells in critically ill patients with sepsis. Crit. Care Med. 45, 875\u2013882 (2017).","journal-title":"Crit. Care Med."},{"key":"BFnrneph2017165_CR122","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/SHK.0000000000000619","volume":"46","author":"K Suzuki","year":"2016","unstructured":"Suzuki, K.  et al. Reduced immunocompetent B cells and increased secondary infection in elderly patients with severe sepsis. Shock 46, 270\u2013278 (2016).","journal-title":"Shock"},{"key":"BFnrneph2017165_CR123","doi-asserted-by":"publisher","first-page":"R247","DOI":"10.1186\/cc13073","volume":"17","author":"EJ Giamarellos-Bourboulis","year":"2013","unstructured":"Giamarellos-Bourboulis, E. J.  et al. Kinetics of circulating immunoglobulin M in sepsis: relationship with final outcome. Crit. Care 17, R247 (2013).","journal-title":"Crit. Care"},{"key":"BFnrneph2017165_CR124","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.12659\/MSM.895421","volume":"22","author":"X Pan","year":"2016","unstructured":"Pan, X., Ji, Z. & Xue, J. Percentage of peripheral CD19+CD24hiCD38hi regulatory B cells in neonatal sepsis patients and its functional implication. Med. Sci. Monit. 22, 2374\u20132378 (2016).","journal-title":"Med. Sci. Monit."},{"key":"BFnrneph2017165_CR125","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1189\/jlb.5MR0114-067R","volume":"96","author":"J Cabrera-Perez","year":"2014","unstructured":"Cabrera-Perez, J., Condotta, S. A., Badovinac, V. P. & Griffith, T. S. Impact of sepsis on CD4 T cell immunity. J. Leukoc. Biol. 96, 767\u2013777 (2014).","journal-title":"J. Leukoc. Biol."},{"key":"BFnrneph2017165_CR126","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1615\/CritRevImmunol.2016017098","volume":"36","author":"DB Danahy","year":"2016","unstructured":"Danahy, D. B., Strother, R. K., Badovinac, V. P. & Griffith, T. S. Clinical and experimental sepsis impairs CD8 T-cell-mediated immunity. Crit. Rev. Immunol. 36, 57\u201374 (2016).","journal-title":"Crit. Rev. Immunol."},{"key":"BFnrneph2017165_CR127","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1001\/jama.2011.1829","volume":"306","author":"JS Boomer","year":"2011","unstructured":"Boomer, J. S.  et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 306, 2594\u20132605 (2011).","journal-title":"JAMA"},{"key":"BFnrneph2017165_CR128","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13054-016-1182-z","volume":"20","author":"A Spec","year":"2016","unstructured":"Spec, A.  et al. T cells from patients with Candida sepsis display a suppressive immunophenotype. Crit. Care 20, 15 (2016).","journal-title":"Crit. Care"},{"key":"BFnrneph2017165_CR129","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1189\/jlb.5AB1114-545R","volume":"97","author":"J Demaret","year":"2015","unstructured":"Demaret, J.  et al. STAT5 phosphorylation in T cell subsets from septic patients in response to recombinant human interleukin-7: a pilot study. J. Leukoc. Biol. 97, 791\u2013796 (2015).","journal-title":"J. Leukoc. Biol."},{"key":"BFnrneph2017165_CR130","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1097\/ALN.0000000000001031","volume":"124","author":"V van der Heide","year":"2016","unstructured":"van der Heide, V., Mohnle, P., Rink, J., Briegel, J. & Kreth, S. Down-regulation of microRNA-31 in CD4+ T cells contributes to immunosuppression in human sepsis by promoting TH2 skewing. Anesthesiology 124, 908\u2013922 (2016).","journal-title":"Anesthesiology"},{"key":"BFnrneph2017165_CR131","doi-asserted-by":"publisher","first-page":"R112","DOI":"10.1186\/cc11404","volume":"16","author":"JS Boomer","year":"2012","unstructured":"Boomer, J. S., Shuherk-Shaffer, J., Hotchkiss, R. S. & Green, J. M. A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis. Crit. Care 16, R112 (2012).","journal-title":"Crit. Care"},{"key":"BFnrneph2017165_CR132","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/CCM.0b013e3182657948","volume":"41","author":"F Venet","year":"2013","unstructured":"Venet, F.  et al. Decreased T cell repertoire diversity in sepsis: a preliminary study. Crit. Care Med. 41, 111\u2013119 (2013).","journal-title":"Crit. Care Med."},{"key":"BFnrneph2017165_CR133","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1007\/s00134-008-1337-8","volume":"35","author":"F Venet","year":"2009","unstructured":"Venet, F.  et al. Increased circulating regulatory T cells (CD4+CD25+CD127\u2212) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med. 35, 678\u2013686 (2009).","journal-title":"Intensive Care Med."},{"key":"BFnrneph2017165_CR134","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1189\/jlb.0607371","volume":"83","author":"F Venet","year":"2008","unstructured":"Venet, F.  et al. Regulatory T cell populations in sepsis and trauma. J. Leukoc. Biol. 83, 523\u2013535 (2008).","journal-title":"J. Leukoc. Biol."},{"key":"BFnrneph2017165_CR135","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1097\/CCM.0b013e3181e78ad0","volume":"38","author":"DC Nascimento","year":"2010","unstructured":"Nascimento, D. C.  et al. Role of regulatory T cells in long-term immune dysfunction associated with severe sepsis. Crit. Care Med. 38, 1718\u20131725 (2010).","journal-title":"Crit. Care Med."},{"key":"BFnrneph2017165_CR136","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ijid.2014.11.006","volume":"30","author":"H Huang","year":"2014","unstructured":"Huang, H.  et al. High circulating CD39+ regulatory T cells predict poor survival for sepsis patients. Int. J. Infect. Dis. 30, 57\u201363 (2014).","journal-title":"Int. J. Infect. Dis."},{"key":"BFnrneph2017165_CR137","doi-asserted-by":"publisher","first-page":"14919","DOI":"10.1038\/ncomms14919","volume":"8","author":"DC Nascimento","year":"2017","unstructured":"Nascimento, D. C.  et al. IL-33 contributes to sepsis-induced long-term immunosuppression by expanding the regulatory T cell population. Nat. Commun. 8, 14919 (2017).","journal-title":"Nat. Commun."},{"key":"BFnrneph2017165_CR138","doi-asserted-by":"publisher","first-page":"6952","DOI":"10.4049\/jimmunol.166.11.6952","volume":"166","author":"RS Hotchkiss","year":"2001","unstructured":"Hotchkiss, R. S.  et al. Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J. Immunol. 166, 6952\u20136963 (2001).","journal-title":"J. Immunol."},{"key":"BFnrneph2017165_CR139","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.4049\/jimmunol.174.6.3765","volume":"174","author":"KA Felmet","year":"2005","unstructured":"Felmet, K. A., Hall, M. W., Clark, R. S., Jaffe, R. & Carcillo, J. A. Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure. J. Immunol. 174, 3765\u20133772 (2005).","journal-title":"J. Immunol."},{"key":"BFnrneph2017165_CR140","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/00024382-200206000-00001","volume":"17","author":"SG Muehlstedt","year":"2002","unstructured":"Muehlstedt, S. G., Lyte, M. & Rodriguez, J. L. Increased IL-10 production and HLA-DR suppression in the lungs of injured patients precede the development of nosocomial pneumonia. Shock 17, 443\u2013450 (2002).","journal-title":"Shock"},{"key":"BFnrneph2017165_CR141","doi-asserted-by":"publisher","first-page":"R285","DOI":"10.1186\/cc13148","volume":"17","author":"K Chalk","year":"2013","unstructured":"Chalk, K.  et al. Dysfunction of alveolar macrophages after cardiac surgery and postoperative pneumonia? \u2014 An observational study. Crit. Care 17, R285 (2013).","journal-title":"Crit. Care"},{"key":"BFnrneph2017165_CR142","doi-asserted-by":"publisher","first-page":"e0164489","DOI":"10.1371\/journal.pone.0164489","volume":"11","author":"V Faivre","year":"2016","unstructured":"Faivre, V., Lukaszewicz, A. C. & Payen, D. Downregulation of blood monocyte HLA-DR in ICU patients is also present in bone marrow cells. PLoS ONE 11, e0164489 (2016).","journal-title":"PLoS ONE"},{"key":"BFnrneph2017165_CR143","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13287-015-0135-9","volume":"6","author":"T Skirecki","year":"2015","unstructured":"Skirecki, T.  et al. Early severe impairment of hematopoietic stem and progenitor cells from the bone marrow caused by CLP sepsis and endotoxemia in a humanized mice model. Stem Cell Res. Ther. 6, 142 (2015).","journal-title":"Stem Cell Res. Ther."},{"key":"BFnrneph2017165_CR144","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.1182\/blood-2009-04-214916","volume":"114","author":"S Rodriguez","year":"2009","unstructured":"Rodriguez, S.  et al. Dysfunctional expansion of hematopoietic stem cells and block of myeloid differentiation in lethal sepsis. Blood 114, 4064\u20134076 (2009).","journal-title":"Blood"},{"key":"BFnrneph2017165_CR145","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/SHK.0000000000000842","volume":"48","author":"C Netzer","year":"2017","unstructured":"Netzer, C.  et al. Apoptotic diminution of immature single and double positive thymocyte subpopulations contributes to thymus involution during murine polymicrobial sepsis. Shock 48, 215\u2013226 (2017).","journal-title":"Shock"},{"key":"BFnrneph2017165_CR146","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1002\/stem.2464","volume":"34","author":"Y Kong","year":"2016","unstructured":"Kong, Y.  et al. Sepsis-induced thymic atrophy is associated with defects in early lymphopoiesis. Stem Cells 34, 2902\u20132915 (2016).","journal-title":"Stem Cells"},{"key":"BFnrneph2017165_CR147","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1677\/JOE-09-0179","volume":"203","author":"AL Gruver","year":"2009","unstructured":"Gruver, A. L., Ventevogel, M. S. & Sempowski, G. D. Leptin receptor is expressed in thymus medulla and leptin protects against thymic remodeling during endotoxemia-induced thymus involution. J. Endocrinol. 203, 75\u201385 (2009).","journal-title":"J. Endocrinol."},{"key":"BFnrneph2017165_CR148","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1213\/ane.0b013e318195e11d","volume":"108","author":"C Torgersen","year":"2009","unstructured":"Torgersen, C.  et al. Macroscopic postmortem findings in 235 surgical intensive care patients with sepsis. Anesth. Analg 108, 1841\u20131847 (2009).","journal-title":"Anesth. Analg"},{"key":"BFnrneph2017165_CR149","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1086\/591859","volume":"29","author":"C Landelle","year":"2008","unstructured":"Landelle, C.  et al. Nosocomial infection after septic shock among intensive care unit patients. Infect. Control Hosp. Epidemiol. 29, 1054\u20131065 (2008).","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"BFnrneph2017165_CR150","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1001\/jama.2016.2691","volume":"315","author":"LA van Vught","year":"2016","unstructured":"van Vught, L. A.  et al. Incidence, risk factors, and attributable mortality of secondary infections in the intensive care unit after admission for sepsis. JAMA 315, 1469\u20131479 (2016).","journal-title":"JAMA"},{"key":"BFnrneph2017165_CR151","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/SHK.0000000000000731","volume":"47","author":"RM Koch","year":"2017","unstructured":"Koch, R. M.  et al. Patterns in bacterial- and viral-induced immunosuppression and secondary infections in the ICU. Shock 47, 5\u201312 (2017).","journal-title":"Shock"},{"issue":"Suppl. 1","key":"BFnrneph2017165_CR152","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.3109\/13693786.2010.509744","volume":"49","author":"G Monneret","year":"2011","unstructured":"Monneret, G., Venet, F., Kullberg, B. J. & Netea, M. G. ICU-acquired immunosuppression and the risk for secondary fungal infections. Med. Mycol. 49 (Suppl. 1), S17\u2013S23 (2011).","journal-title":"Med. Mycol."},{"key":"BFnrneph2017165_CR153","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1056\/NEJMra0808853","volume":"360","author":"BH Segal","year":"2009","unstructured":"Segal, B. H. Aspergillosis. N. Engl. J. Med. 360, 1870\u20131884 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2017165_CR154","doi-asserted-by":"publisher","first-page":"e98819","DOI":"10.1371\/journal.pone.0098819","volume":"9","author":"AH Walton","year":"2014","unstructured":"Walton, A. H.  et al. Reactivation of multiple viruses in patients with sepsis. PLoS ONE 9, e98819 (2014).","journal-title":"PLoS ONE"},{"key":"BFnrneph2017165_CR155","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1093\/cid\/cix120","volume":"64","author":"DSY Ong","year":"2017","unstructured":"Ong, D. S. Y.  et al. Epidemiology of multiple herpes viremia in previously immunocompetent patients with septic shock. Clin. Infect. Dis. 64, 1204\u20131210 (2017).","journal-title":"Clin. Infect. Dis."},{"key":"BFnrneph2017165_CR156","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1097\/MCC.0b013e32830f1e12","volume":"14","author":"CE Luyt","year":"2008","unstructured":"Luyt, C. E., Combes, A., Nieszkowska, A., Trouillet, J. L. & Chastre, J. Viral infections in the ICU. Curr. Opin. Crit. Care 14, 605\u2013608 (2008).","journal-title":"Curr. Opin. Crit. Care"},{"key":"BFnrneph2017165_CR157","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00134-015-4071-z","volume":"42","author":"DS Ong","year":"2016","unstructured":"Ong, D. S.  et al. Cytomegalovirus reactivation and mortality in patients with acute respiratory distress syndrome. Intensive Care Med. 42, 333\u2013341 (2016).","journal-title":"Intensive Care Med."},{"key":"BFnrneph2017165_CR158","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1097\/CCM.0b013e3181a3aa43","volume":"37","author":"AC Kalil","year":"2009","unstructured":"Kalil, A. C. & Florescu, D. F. Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit. Crit. Care Med. 37, 2350\u20132358 (2009).","journal-title":"Crit. Care Med."},{"key":"BFnrneph2017165_CR159","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1097\/CCM.0b013e31819ffea6","volume":"37","author":"L Chiche","year":"2009","unstructured":"Chiche, L.  et al. Active cytomegalovirus infection is common in mechanically ventilated medical intensive care unit patients. Crit. Care Med. 37, 1850\u20131857 (2009).","journal-title":"Crit. Care Med."},{"key":"BFnrneph2017165_CR160","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/CCM.0000000000000712","volume":"43","author":"DS Ong","year":"2015","unstructured":"Ong, D. S.  et al. Cytomegalovirus seroprevalence as a risk factor for poor outcome in acute respiratory distress syndrome*. Crit. Care Med. 43, 394\u2013400 (2015).","journal-title":"Crit. Care Med."},{"key":"BFnrneph2017165_CR161","doi-asserted-by":"publisher","first-page":"S663","DOI":"10.1097\/CCM.0b013e3181f20319","volume":"38","author":"AC Kalil","year":"2010","unstructured":"Kalil, A. C., Sun, J. & Florescu, D. F. The importance of detecting cytomegalovirus infections in studies evaluating new therapies for severe sepsis. Crit. Care Med. 38, S663\u2013667 (2010).","journal-title":"Crit. Care Med."},{"key":"BFnrneph2017165_CR162","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1097\/CCM.0000000000000859","volume":"43","author":"AJ Goodwin","year":"2015","unstructured":"Goodwin, A. J., Rice, D. A., Simpson, K. N. & Ford, D. W. Frequency, cost, and risk factors of readmissions among severe sepsis survivors. Crit. Care Med. 43, 738\u2013746 (2015).","journal-title":"Crit. Care Med."},{"key":"BFnrneph2017165_CR163","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1164\/rccm.201403-0471OC","volume":"190","author":"HC Prescott","year":"2014","unstructured":"Prescott, H. C., Langa, K. M., Liu, V., Escobar, G. J. & Iwashyna, T. J. Increased 1-year healthcare use in survivors of severe sepsis. Am. J. Respir. Crit. Care Med. 190, 62\u201369 (2014).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnrneph2017165_CR164","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11908-016-0544-7","volume":"18","author":"M Shankar-Hari","year":"2016","unstructured":"Shankar-Hari, M. & Rubenfeld, G. D. Understanding long-term outcomes following sepsis: implications and challenges. Curr. Infect. Dis. Rep. 18, 37 (2016).","journal-title":"Curr. Infect. Dis. Rep."},{"key":"BFnrneph2017165_CR165","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1097\/CCM.0000000000001159","volume":"43","author":"DW Chang","year":"2015","unstructured":"Chang, D. W., Tseng, C. H. & Shapiro, M. F. Rehospitalizations following sepsis: common and costly. Crit. Care Med. 43, 2085\u20132093 (2015).","journal-title":"Crit. Care Med."},{"key":"BFnrneph2017165_CR166","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1097\/CCM.0000000000000693","volume":"43","author":"A Ortego","year":"2015","unstructured":"Ortego, A.  et al. Hospital-based acute care use in survivors of septic shock. Crit. Care Med. 43, 729\u2013737 (2015).","journal-title":"Crit. Care Med."},{"key":"BFnrneph2017165_CR167","doi-asserted-by":"publisher","first-page":"i2375","DOI":"10.1136\/bmj.i2375","volume":"353","author":"HC Prescott","year":"2016","unstructured":"Prescott, H. C., Osterholzer, J. J., Langa, K. M., Angus, D. C. & Iwashyna, T. J. Late mortality after sepsis: propensity matched cohort study. BMJ 353, i2375 (2016).","journal-title":"BMJ"},{"key":"BFnrneph2017165_CR168","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1097\/CCM.0000000000001464","volume":"44","author":"A Sun","year":"2016","unstructured":"Sun, A.  et al. Association between index hospitalization and hospital readmission in sepsis survivors. Crit. Care Med. 44, 478\u2013487 (2016).","journal-title":"Crit. Care Med."},{"key":"BFnrneph2017165_CR169","doi-asserted-by":"publisher","first-page":"e004283","DOI":"10.1136\/bmjopen-2013-004283","volume":"4","author":"HE Wang","year":"2014","unstructured":"Wang, H. E.  et al. Long-term mortality after community-acquired sepsis: a longitudinal population-based cohort study. BMJ Open 4, e004283 (2014).","journal-title":"BMJ Open"},{"key":"BFnrneph2017165_CR170","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1097\/CCM.0000000000000503","volume":"42","author":"A Linder","year":"2014","unstructured":"Linder, A.  et al. Long-term (10-year) mortality of younger previously healthy patients with severe sepsis\/septic shock is worse than that of patients with nonseptic critical illness and of the general population. Crit. Care Med. 42, 2211\u20132218 (2014).","journal-title":"Crit. Care Med."},{"key":"BFnrneph2017165_CR171","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/CCM.0000000000002074","volume":"45","author":"JC Mira","year":"2017","unstructured":"Mira, J. C.  et al. Sepsis pathophysiology, chronic critical illness, and persistent inflammation-immunosuppression and catabolism syndrome. Crit. Care Med. 45, 253\u2013262 (2017).","journal-title":"Crit. Care Med."},{"key":"BFnrneph2017165_CR172","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1172\/JCI82224","volume":"126","author":"MJ Delano","year":"2016","unstructured":"Delano, M. J. & Ward, P. A. Sepsis-induced immune dysfunction: can immune therapies reduce mortality? J. Clin. Invest. 126, 23\u201331 (2016).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2017165_CR173","doi-asserted-by":"publisher","unstructured":"Nomellini, V., Kaplan, L. J., Sims, C. A. & Caldwell, C. C. Chronic critical illness and persistent inflammation: what can we learn from the elderly, injured, septic, and malnourished? Shock http:\/\/dx.doi.org\/10.1097\/SHK.0000000000000939 (2017).","DOI":"10.1097\/SHK.0000000000000939"},{"key":"BFnrneph2017165_CR174","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13613-017-0304-3","volume":"7","author":"V Zorio","year":"2017","unstructured":"Zorio, V.  et al. Assessment of sepsis-induced immunosuppression at ICU discharge and 6 months after ICU discharge. Ann. Intensive Care 7, 80 (2017).","journal-title":"Ann. Intensive Care"},{"key":"BFnrneph2017165_CR175","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s11908-007-0059-3","volume":"9","author":"S Yende","year":"2007","unstructured":"Yende, S. & Angus, D. C. Long-term outcomes from sepsis. Curr. Infect. Dis. Rep. 9, 382\u2013386 (2007).","journal-title":"Curr. Infect. Dis. Rep."},{"key":"BFnrneph2017165_CR176","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13054-016-1233-5","volume":"20","author":"C Arens","year":"2016","unstructured":"Arens, C.  et al. Sepsis-induced long-term immune paralysis - results of a descriptive, explorative study. Crit. Care 20, 93 (2016).","journal-title":"Crit. Care"},{"key":"BFnrneph2017165_CR177","doi-asserted-by":"publisher","first-page":"4781","DOI":"10.4049\/jimmunol.1700142","volume":"198","author":"F Borken","year":"2017","unstructured":"Borken, F.  et al. Chronic critical illness from sepsis is associated with an enhanced TCR response. J. Immunol. 198, 4781\u20134791 (2017).","journal-title":"J. Immunol."},{"key":"BFnrneph2017165_CR178","doi-asserted-by":"publisher","unstructured":"Oliveira, N. M.  et al. Sepsis induces telomere shortening: a potential mechanism responsible for delayed pathophysiological events in sepsis survivors? Mol. Med. http:\/\/dx.doi.org\/10.2119\/molmed.2016.00225 (2016).","DOI":"10.2119\/molmed.2016.00225"},{"key":"BFnrneph2017165_CR179","doi-asserted-by":"publisher","first-page":"4807853","DOI":"10.1155\/2017\/4807853","volume":"2017","author":"V Nguyen","year":"2017","unstructured":"Nguyen, V., Mendelsohn, A. & Larrick, J. W. Interleukin-7 and immunosenescence. J. Immunol. Res. 2017, 4807853 (2017).","journal-title":"J. Immunol. Res."},{"key":"BFnrneph2017165_CR180","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/imr.12418","volume":"271","author":"MS Chaudhry","year":"2016","unstructured":"Chaudhry, M. S., Velardi, E., Dudakov, J. A. & van den Brink, M. R. Thymus: the next (re)generation. Immunol. Rev. 271, 56\u201371 (2016).","journal-title":"Immunol. Rev."},{"key":"BFnrneph2017165_CR181","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","volume":"44","author":"B Shakoory","year":"2016","unstructured":"Shakoory, B.  et al. Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial. Crit. Care Med. 44, 275\u2013281 (2016).","journal-title":"Crit. Care Med."},{"key":"BFnrneph2017165_CR182","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1097\/01.CCM.0000145229.59014.6C","volume":"32","author":"EA Panacek","year":"2004","unstructured":"Panacek, E. A.  et al. Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels. Crit. Care Med. 32, 2173\u20132182 (2004).","journal-title":"Crit. Care Med."},{"key":"BFnrneph2017165_CR183","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1164\/rccm.200204-302OC","volume":"166","author":"PQ Eichacker","year":"2002","unstructured":"Eichacker, P. Q.  et al. Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis. Am. J. Respir. Crit. Care Med. 166, 1197\u20131205 (2002).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnrneph2017165_CR184","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1182\/blood-2004-08-3251","volume":"105","author":"CF Benjamim","year":"2005","unstructured":"Benjamim, C. F., Lundy, S. K., Lukacs, N. W., Hogaboam, C. M. & Kunkel, S. L. Reversal of long-term sepsis-induced immunosuppression by dendritic cells. Blood 105, 3588\u20133595 (2005).","journal-title":"Blood"},{"key":"BFnrneph2017165_CR185","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1093\/infdis\/jis383","volume":"206","author":"J Unsinger","year":"2012","unstructured":"Unsinger, J.  et al. Interleukin-7 ameliorates immune dysfunction and improves survival in a 2-hit model of fungal sepsis. J. Infect. Dis. 206, 606\u2013616 (2012).","journal-title":"J. Infect. Dis."},{"key":"BFnrneph2017165_CR186","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/eji.201646875","volume":"47","author":"L Dyck","year":"2017","unstructured":"Dyck, L. & Mills, K. H. G. Immune checkpoints and their inhibition in cancer and infectious diseases. Eur. J. Immunol. 47, 765\u2013779 (2017).","journal-title":"Eur. J. Immunol."},{"key":"BFnrneph2017165_CR187","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1056\/NEJMcibr1404664","volume":"371","author":"RS Hotchkiss","year":"2014","unstructured":"Hotchkiss, R. S. & Moldawer, L. L. Parallels between cancer and infectious disease. N. Engl. J. Med. 371, 380\u2013383 (2014).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2017165_CR188","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1093\/annonc\/mdx179","volume":"28","author":"T Shekarian","year":"2017","unstructured":"Shekarian, T.  et al. Pattern recognition receptors: immune targets to enhance cancer immunotherapy. Ann. Oncol. 28, 1756\u20131766 (2017).","journal-title":"Ann. Oncol."},{"key":"BFnrneph2017165_CR189","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1183\/09031936.00152612","volume":"42","author":"A Roquilly","year":"2013","unstructured":"Roquilly, A.  et al. TLR-4 agonist in post-haemorrhage pneumonia: role of dendritic and natural killer cells. Eur. Respir. J. 42, 1365\u20131378 (2013).","journal-title":"Eur. Respir. J."},{"key":"BFnrneph2017165_CR190","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jss.2012.09.039","volume":"182","author":"CG Davis","year":"2013","unstructured":"Davis, C. G.  et al. TLR3 agonist improves survival to secondary pneumonia in a double injury model. J. Surg. Res. 182, 270\u2013276 (2013).","journal-title":"J. Surg. Res."},{"key":"BFnrneph2017165_CR191","doi-asserted-by":"publisher","first-page":"6496","DOI":"10.4049\/jimmunol.165.11.6496","volume":"165","author":"GH Chen","year":"2000","unstructured":"Chen, G. H.  et al. Intrapulmonary TNF gene therapy reverses sepsis-induced suppression of lung antibacterial host defense. J. Immunol. 165, 6496\u20136503 (2000).","journal-title":"J. Immunol."},{"key":"BFnrneph2017165_CR192","doi-asserted-by":"publisher","first-page":"R8","DOI":"10.1186\/cc11932","volume":"17","author":"J Wu","year":"2013","unstructured":"Wu, J.  et al. The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial. Crit. Care 17, R8 (2013).","journal-title":"Crit. Care"},{"key":"BFnrneph2017165_CR193","unstructured":"US National Library of Medicine. ClinicalTrials.gov http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02867267 (2017)."},{"key":"BFnrneph2017165_CR194","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.molmed.2014.01.002","volume":"20","author":"NA Hutchins","year":"2014","unstructured":"Hutchins, N. A., Unsinger, J., Hotchkiss, R. S. & Ayala, A. The new normal: immunomodulatory agents against sepsis immune suppression. Trends Mol. Med. 20, 224\u2013233 (2014).","journal-title":"Trends Mol. Med."},{"key":"BFnrneph2017165_CR195","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1097\/00003246-200207000-00015","volume":"30","author":"G Nakos","year":"2002","unstructured":"Nakos, G.  et al. Immunoparalysis in patients with severe trauma and the effect of inhaled interferon-gamma. Crit. Care Med. 30, 1488\u20131494 (2002).","journal-title":"Crit. Care Med."},{"key":"BFnrneph2017165_CR196","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1164\/ajrccm.185.1.110","volume":"185","author":"M Nalos","year":"2012","unstructured":"Nalos, M.  et al. Immune effects of interferon gamma in persistent staphylococcal sepsis. Am. J. Respir. Crit. Care Med. 185, 110\u2013112 (2012).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnrneph2017165_CR197","first-page":"2746","volume":"37","author":"AC Lukaszewicz","year":"2009","unstructured":"Lukaszewicz, A. C.  et al. Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction. Crit. Care Med. 37, 2746\u20132752 (2009).","journal-title":"Crit. Care Med."},{"key":"BFnrneph2017165_CR198","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/1471-2334-14-166","volume":"14","author":"CE Delsing","year":"2014","unstructured":"Delsing, C. E.  et al. Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series. BMC Infect. Dis. 14, 166 (2014).","journal-title":"BMC Infect. Dis."},{"key":"BFnrneph2017165_CR199","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S1473-3099(16)30541-2","volume":"17","author":"D Grimaldi","year":"2017","unstructured":"Grimaldi, D., Pradier, O., Hotchkiss, R. S. & Vincent, J. L. Nivolumab plus interferon-gamma in the treatment of intractable mucormycosis. Lancet Infect. Dis. 17, 18 (2017).","journal-title":"Lancet Infect. Dis."},{"key":"BFnrneph2017165_CR200","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/bjh.14595","volume":"177","author":"MT Cutino-Moguel","year":"2017","unstructured":"Cutino-Moguel, M. T., Eades, C., Rezvani, K. & Armstrong-James, D. Immunotherapy for infectious diseases in haematological immunocompromise. Br. J. Haematol. 177, 348\u2013356 (2017).","journal-title":"Br. J. Haematol."},{"key":"BFnrneph2017165_CR201","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00134-010-2088-x","volume":"37","author":"MW Hall","year":"2011","unstructured":"Hall, M. W.  et al. Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome. Intensive Care Med. 37, 525\u2013532 (2011).","journal-title":"Intensive Care Med."},{"key":"BFnrneph2017165_CR202","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S1081-1206(10)60885-X","volume":"98","author":"LA Nelson","year":"2007","unstructured":"Nelson, L. A. Use of granulocyte-macrophage colony-stimulating factor to reverse anergy in otherwise immunologically healthy children. Ann. Allergy Asthma Immunol. 98, 373\u2013382 (2007).","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"BFnrneph2017165_CR203","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1006\/cyto.2002.1037","volume":"18","author":"V Drossou-Agakidou","year":"2002","unstructured":"Drossou-Agakidou, V.  et al. In vivo effect of rhGM-CSF And rhG-CSF on monocyte HLA-DR expression of septic neonates. Cytokine 18, 260\u2013265 (2002).","journal-title":"Cytokine"},{"key":"BFnrneph2017165_CR204","first-page":"804","volume":"42","author":"A Protti","year":"2014","unstructured":"Protti, A.  et al. Granulocyte-macrophage colony stimulating factor for non-resolving legionellosis. Anaesth. Intensive Care 42, 804\u2013806 (2014).","journal-title":"Anaesth. Intensive Care"},{"key":"BFnrneph2017165_CR205","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1164\/rccm.200903-0363OC","volume":"180","author":"C Meisel","year":"2009","unstructured":"Meisel, C.  et al. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am. J. Respir. Crit. Care Med. 180, 640\u2013648 (2009).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnrneph2017165_CR206","doi-asserted-by":"publisher","first-page":"e2044","DOI":"10.1097\/MD.0000000000002044","volume":"94","author":"B Mathias","year":"2015","unstructured":"Mathias, B., Szpila, B. E., Moore, F. A., Efron, P. A. & Moldawer, L. L. A. Review of GM-CSF therapy in sepsis. Medicine 94, e2044 (2015).","journal-title":"Medicine"},{"key":"BFnrneph2017165_CR207","unstructured":"US National Library of Medicine. ClinicalTrials.gov http:\/\/clinicaltrials.gov\/ct2\/show\/NCT02361528 (2016)."},{"key":"BFnrneph2017165_CR208","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nri2970","volume":"11","author":"CL Mackall","year":"2011","unstructured":"Mackall, C. L., Fry, T. J. & Gress, R. E. Harnessing the biology of IL-7 for therapeutic application. Nat. Rev. Immunol. 11, 330\u2013342 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrneph2017165_CR209","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.smim.2012.02.005","volume":"24","author":"W Lundstrom","year":"2012","unstructured":"Lundstrom, W., Fewkes, N. M. & Mackall, C. L. IL-7 in human health and disease. Semin. Immunol. 24, 218\u2013224 (2012).","journal-title":"Semin. Immunol."},{"key":"BFnrneph2017165_CR210","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.immuni.2016.05.012","volume":"44","author":"A Terashima","year":"2016","unstructured":"Terashima, A.  et al. Sepsis-induced osteoblast ablation causes immunodeficiency. Immunity 44, 1434\u20131443 (2016).","journal-title":"Immunity"},{"key":"BFnrneph2017165_CR211","doi-asserted-by":"publisher","first-page":"5073","DOI":"10.4049\/jimmunol.1202062","volume":"189","author":"F Venet","year":"2012","unstructured":"Venet, F.  et al. IL-7 restores lymphocyte functions in septic patients. J. Immunol. 189, 5073\u20135081 (2012).","journal-title":"J. Immunol."},{"key":"BFnrneph2017165_CR212","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1126\/science.aaf2807","volume":"354","author":"KE Pauken","year":"2016","unstructured":"Pauken, K. E.  et al. Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade. Science 354, 1160\u20131165 (2016).","journal-title":"Science"},{"key":"BFnrneph2017165_CR213","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/SHK.0000000000000317","volume":"43","author":"Y Shindo","year":"2015","unstructured":"Shindo, Y., Unsinger, J., Burnham, C. A., Green, J. M. & Hotchkiss, R. S. Interleukin-7 and anti-programmed cell death 1 antibody have differing effects to reverse sepsis-induced immunosuppression. Shock 43, 334\u2013343 (2015).","journal-title":"Shock"},{"key":"BFnrneph2017165_CR214","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1172\/JCI83871","volume":"125","author":"Y Yang","year":"2015","unstructured":"Yang, Y. Cancer immunotherapy: harnessing the immune system to battle cancer. J. Clin. Invest. 125, 3335\u20133337 (2015).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2017165_CR215","unstructured":"US National Library of Medicine. ClinicalTrials.gov http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02797431 (2017)."},{"key":"BFnrneph2017165_CR216","unstructured":"US National Library of Medicine. ClinicalTrials.gov http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02640807 (2017)."},{"key":"BFnrneph2017165_CR217","doi-asserted-by":"publisher","first-page":"R3","DOI":"10.1186\/cc13176","volume":"18","author":"K Chang","year":"2014","unstructured":"Chang, K.  et al. Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis. Crit. Care 18, R3 (2014).","journal-title":"Crit. Care"},{"key":"BFnrneph2017165_CR218","doi-asserted-by":"publisher","first-page":"R85","DOI":"10.1186\/cc12711","volume":"17","author":"KC Chang","year":"2013","unstructured":"Chang, K. C.  et al. Blockade ofthe negative co-stimulatory molecules PD-1 and CTLA-4 improves survival in primary and secondary fungal sepsis. Crit. Care 17, R85 (2013).","journal-title":"Crit. Care"},{"key":"BFnrneph2017165_CR219","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1189\/jlb.0110037","volume":"88","author":"P Brahmamdam","year":"2010","unstructured":"Brahmamdam, P.  et al. Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis. J. Leukoc. Biol. 88, 233\u2013240 (2010).","journal-title":"J. Leukoc. Biol."},{"key":"BFnrneph2017165_CR220","doi-asserted-by":"publisher","first-page":"R220","DOI":"10.1186\/cc9354","volume":"14","author":"Y Zhang","year":"2010","unstructured":"Zhang, Y.  et al. PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction. Crit. Care 14, R220 (2010).","journal-title":"Crit. Care"},{"key":"BFnrneph2017165_CR221","unstructured":"US National Library of Medicine. ClinicalTrials.gov http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02960854 (2017)."},{"key":"BFnrneph2017165_CR222","unstructured":"US National Library of Medicine. ClinicalTrials.gov http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02576457 (2017)."},{"key":"BFnrneph2017165_CR223","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S1473-3099(15)70112-X","volume":"15","author":"J Cohen","year":"2015","unstructured":"Cohen, J.  et al. Sepsis: a roadmap for furure research Lancet Infect. Dis. 15, 581\u2013614 (2015).","journal-title":"Lancet Infect. Dis."},{"key":"BFnrneph2017165_CR224","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1007\/s00134-017-4821-1","volume":"43","author":"A Perner","year":"2017","unstructured":"Perner, A.  et al. The intensive care medicine research agenda on septic shock. Intensive Care Med. 43, 1294\u20131305 (2017).","journal-title":"Intensive Care Med."},{"key":"BFnrneph2017165_CR225","doi-asserted-by":"publisher","first-page":"64","DOI":"10.2119\/2007-00102.Monneret","volume":"14","author":"G Monneret","year":"2008","unstructured":"Monneret, G., Venet, F., Pachot, A. & Lepape, A. Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol. Med. 14, 64\u201378 (2008).","journal-title":"Mol. Med."},{"key":"BFnrneph2017165_CR226","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s00134-017-4805-1","volume":"43","author":"E Peronnet","year":"2017","unstructured":"Peronnet, E.  et al. Association between mRNA expression of CD74 and IL10 and risk of ICU-acquired infections: a multicenter cohort study. Intensive Care Med. 43, 1013\u20131020 (2017).","journal-title":"Intensive Care Med."},{"issue":"Suppl. 1","key":"BFnrneph2017165_CR227","doi-asserted-by":"publisher","first-page":"A1012","DOI":"10.1186\/2197-425X-3-S1-A1012","volume":"3","author":"CL Sprung","year":"2015","unstructured":"Sprung, C. L.  et al. Comparison of cd64 levels performed by the facs and accellix systems. Intensive Care Med Exp 3 (Suppl. 1), A1012 (2015).","journal-title":"Intensive Care Med Exp"},{"key":"BFnrneph2017165_CR228","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40635-017-0156-z","volume":"5","author":"M Zouiouich","year":"2017","unstructured":"Zouiouich, M., Gossez, M., Venet, F., Rimmele, T. & Monneret, G. Automated bedside flow cytometer for mHLA-DR expression measurement: a comparison study with reference protocol. Intensive Care Med. Exp. 5, 39 (2017).","journal-title":"Intensive Care Med. Exp."},{"key":"BFnrneph2017165_CR229","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/SHK.0000000000000724","volume":"47","author":"G Monneret","year":"2016","unstructured":"Monneret, G.  et al. Novel approach in monocyte intracellular TNF measurement: application to sepsis-induced immune alterations. Shock 47, 318\u2013322 (2016).","journal-title":"Shock"},{"key":"BFnrneph2017165_CR230","doi-asserted-by":"publisher","unstructured":"Letessier, W.  et al. Decreased intra-lymphocyte cytokines measurement in septic shock patients: a proof of concept study in whole blood. Cytokine http:\/\/dx.doi.org\/10.1016\/j.cyto.2017.09.029 (2017).","DOI":"10.1016\/j.cyto.2017.09.029"},{"key":"BFnrneph2017165_CR231","doi-asserted-by":"publisher","first-page":"e015734","DOI":"10.1136\/bmjopen-2016-015734","volume":"7","author":"ML Rol","year":"2017","unstructured":"Rol, M. L.  et al. The REAnimation Low Immune Status Markers (REALISM) project: a protocol for broad characterisation and follow-up of injury-induced immunosuppression in intensive care unit (ICU) critically ill patients. BMJ Open 7, e015734 (2017).","journal-title":"BMJ Open"}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2017.165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2017.165","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nrneph.2017.165","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2017.165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T17:37:21Z","timestamp":1733938641000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2017.165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,11]]},"references-count":231,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["BFnrneph2017165"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2017.165","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,11]]},"assertion":[{"value":"11 December 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}